Caris Life Sciences, Inc. Common Stock (49J)
FSX
Real-time Data
06:00 AM
Day's Range
27.0052 wk Range
12.30Overview - 49J - Caris Life Sciences, Inc. Common Stock
Key Statistics
Valuation
Enterprise Value
6.43B
P/E (Trailing)
‪3.04‬
PEG Ratio
‪-0.03‬
Price / Sales (TTM)
‪7.13‬
Price / Book
‪13.52‬
EV / EBITDA
‪41.56‬
Profitability
Gross Margin
‪68.10%‬
Profit Margin
‪10.62%‬
Operating Margin
‪10.21%‬
Return on Assets
‪8.76%‬
Return on Equity
‪20.12%‬
Ownership
Shares Outstanding
282.58M
Float
134.86M
Held by Insiders
‪48.79%‬
Held by Institutions
‪56.40%‬
Price stats
50-Day Avg
‪20.59‬
200-Day Avg
‪17.87‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 49J - Caris Life Sciences, Inc. Common Stock
Peers - 49J - Caris Life Sciences, Inc. Common Stock
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 49JFSXCaris Life Sciences, Inc. Common Stock7.23BMarket Cap-4.69%52-week change3.05P/E (Trailing)‪10.62%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - 49J - Caris Life Sciences, Inc. Common Stock
About
Caris Life Sciences, Inc. Common Stock is the equity of Caris Life Sciences, a precision medicine and diagnostics company focused on molecular profiling and anatomic pathology services. The company uses advanced molecular information and artificial intelligence to help support cancer detection, disease…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
